- Home
- QSI vs PLX Comparison
QSI vs PLX Comparison
Compare QSI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | PLX |
|---|---|---|
| Founded | 2013 | 1993 |
| Country | United States | United States |
| Employees | 145 | 226 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 159.5M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | QSI | PLX |
|---|---|---|
| Price | $0.85 | $2.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 6.1M | 767.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | $618.07 | N/A |
| P/E Ratio | ★ N/A | $9.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.69 | $1.34 |
| 52 Week High | $3.10 | $3.19 |
Technical Indicators
Market Signals| Indicator | QSI | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 40.93 |
| Support Level | $0.69 | $1.87 |
| Resistance Level | $1.08 | $2.15 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 1.79 | 47.93 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.